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Background: Tissue doppler-derived systolic mitral annular velocity (S’) is a powerful predictor of death, but its ability to forecast lethal 
arrhythmias in ICD and CRT±ICD recipients is unknown. Because longitudinal myocytes are the most sensitive to arrythmogenic triggers, we 
hypothesized that S’, an index of LV long-axis function, might predict VT or VF irrespective of LVEF.
methods: We analyzed 87 ICD (age 66±12y, LVEF 40±17%) and 127 CRT±ICD (age 70±12y, LVEF 26±13%) patients (pts). S’ was averaged from 
medial and lateral mitral annuli velocities. Primary outcome was time to sustained VT or VF.
results: In ICD pts, mean S’ was 5.8±2.0 cm/sec and related to LVEF (r=0.35), intracardiac filling pressures (E/E’; r= - 0.45), and amiodarone 
(r=0.32) and β-blocker use (r=0.23). Over 18 months, 22 (25%) pts had VT/VF, and those who did had a lower S’ than those who did not (Fig 
A). Each 1cm/sec reduction in S’ related to a 31% escalated risk of VT/VF (HR 0.69, 95% CI 0.51-0.93, P=0.01) independently of all covariates 
including LVEF in bivariate analyses. S’ increased model χ2-values implying incremental utility. An S’≤ 6.1cm/sec optimally predicted VT/VF and 
conferred a 4-fold increased hazard (Fig B). In CRT±ICD pts, S’ (mean 4.9±1.4 cm/sec) did not predict VT/VF (15 events over 24 months, P=0.45).
conclusions: Attenuations in S’ relate to an enhanced risk of VT/VF in ICD but not CRT±ICD cohorts possibly due to modulation of systolic function 
by CRT. S’ could be utilised to further refine arrhythmic risk in ICD recipients.
